Immix Biopharma, Inc. (IMMX) Total Assets by Year
Immix Biopharma, Inc. closed fiscal year 2025 with $104.8M in total assets, $11.0M in total liabilities and $93.8M in shareholder equity. This represents an increase of 356.9% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Immix Biopharma, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
IMMX Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
IMMX Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K/A | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $239.1M+1429.3% | $95.8M+381.7% | $104.8M+356.9% | $20.1M-20.1% | $15.6M-45.8% | $19.9M-42.1% | $22.9M+15.2% | $25.1M+11.9% | $28.8M+85.2% | $34.3M+160.0% | $19.9M+33.7% | $22.5M+29.2% |
| Total Liabilities | $10.2M-7.2% | $11.5M+11.2% | $11.0M+13.9% | $11.8M+55.7% | $11.0M+122.1% | $10.3M+53.3% | $9.7M+160.5% | $7.6M+168.7% | $4.9M+106.4% | $6.7M+355.9% | $3.7M+112.9% | $2.8M+337.1% |
| Total Equity | $228.9M+4819.7% | $84.4M+779.4% | $93.8M+607.8% | $8.3M-52.9% | $4.7M-80.5% | $9.6M-65.6% | $13.3M-19.2% | $17.6M-11.2% | $23.9M+80.6% | $27.9M+137.2% | $16.4M+24.7% | $19.8M+18.1% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Immix Biopharma, Inc. financials
Frequently Asked Questions
What was Immix Biopharma, Inc.'s total assets in fiscal year 2025?
Immix Biopharma, Inc. closed fiscal year 2025 with $104.8M in total assets, $11.0M in total liabilities and $93.8M in shareholder equity.
How fast is Immix Biopharma, Inc.'s total assets growing?
Immix Biopharma, Inc. (IMMX) total assets rose by 356.9% year over year, from $22.9M to $104.8M in fiscal year 2025.
How has Immix Biopharma, Inc.'s total assets changed over the years?
Across the 6 fiscal years this page covers, Immix Biopharma, Inc. (IMMX) total assets went from $540K in fiscal year 2020 to $104.8M in fiscal year 2025.
What was Immix Biopharma, Inc.'s total assets in the most recent quarter?
Immix Biopharma, Inc. (IMMX) reported $239.1M in total assets in Q2 2026. This represents an increase of 1429.3% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Immix Biopharma, Inc. (IMMX) reported on that line in every period on record.